India-US trade deal ‘done and dusted’, execution awaits competitive advantage: Goyal
24 Sept, 23:47 IST · Plays out over months · 1 source
India and the US have finalised a trade deal, which should help Indian textiles, drug and software exporters win more US orders, while domestic-focused firms see little change.
Key facts
What the reporting establishes, before any reading of it.
- Goyal says India-US trade deal done and dusted
- Execution awaits competitive advantage
- Progress outlined with EU, Canada, Mexico, GCC, Chile, Peru
How the news spreads
Step by step — from the first companies it hits to whole sectors.
Who it hits first
- Commerce Minister Piyush Goyal says the India-US trade deal is done and dusted, with only execution and final competitive-advantage details left.
- Lower US duties would directly cut costs for Indian exporters of clothes, bedsheets, generic drugs and software services.
- The five map seeds (Coal India, Oil India, GAIL, ABB India and Dabur) are domestic businesses with no US sales channel, so the deal barely touches them.
- Textiles exporters such as Welspun Living and Jindal Worldwide, which sell 41% and 90% of revenue abroad, stand first in line for new orders.
Who may gain
- US-facing textiles makers (bedsheets, garments, fabrics) through lower American tariffs.
- Generic-drug and drug-ingredient exporters through smoother US market access.
- Software and IT hardware firms through friendlier US tech ties and sentiment.
- Cotton, yarn and fabric suppliers at home as exporter order books refill.
- Domestic giants like Coal India, GAIL, Oil India, ABB India and Dabur see no direct gain.
Along the supply chain
Downstream
US retail chains, apparel brands, hospitals and technology buyers receive cheaper Indian goods and services, while Indian exporters expand shipping, warehousing and compliance work.
Upstream
Cotton growers, spinners, weavers and dyeing units, plus drug-ingredient and packaging suppliers, get second-order demand as exporters such as Welspun Living and Jindal Worldwide run fuller order books.
Where demand moves
Business
American retailers and importers place bigger clothing and home-textile orders as duties fall; US drug distributors pull more Indian generics; US firms keep outsourcing software and hardware work — business demand moves from US buyers to Indian exporters.
Capital
Investors rotate toward export-led textiles, pharma and IT shares on better earnings hopes, funding capacity additions; domestic defensives see no such inflow.
How it spreads across sectors
Capital Goods
Neutral — factory equipment demand follows domestic capex, not export duties.
Fast Moving Consumer Goods
Neutral — household brands live on Indian demand, not US trade.
Healthcare
Mildly positive — smoother US access helps drug exporters; hospitals and domestic diagnostics feel nothing.
Information Technology
Mildly positive on sentiment and services continuity; hardware makers gain if tech trade eases.
Oil, Gas & Consumable Fuels
Neutral — refiners and gas utilities sell at home and face no tariff channel.
Textiles
Positive first-order lift — lower US tariffs directly raise exporter volumes and margins.
When it plays out
Immediate
Export shares gap up on headlines; textiles names with confirmed US exposure lead while domestic seeds drift flat.
Medium term
Real order flows and margins decide — exporters with strong balance sheets convert the deal into earnings; pledged or leveraged names lag.